155 related articles for article (PubMed ID: 11592599)
1. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.
Paizis G; Gilbert RE; Cooper ME; Murthi P; Schembri JM; Wu LL; Rumble JR; Kelly DJ; Tikellis C; Cox A; Smallwood RA; Angus PW
J Hepatol; 2001 Sep; 35(3):376-85. PubMed ID: 11592599
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart.
Lamparter S; Sun Y; Weber KT
Cardiovasc Res; 1999 Jul; 43(1):165-72. PubMed ID: 10536701
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.
Paizis G; Cooper ME; Schembri JM; Tikellis C; Burrell LM; Angus PW
Gastroenterology; 2002 Nov; 123(5):1667-76. PubMed ID: 12404241
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 2001 Oct; 34(4 Pt 1):745-50. PubMed ID: 11584371
[TBL] [Abstract][Full Text] [Related]
7. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
Yang L; Bataller R; Dulyx J; Coffman TM; Ginès P; Rippe RA; Brenner DA
J Hepatol; 2005 Aug; 43(2):317-23. PubMed ID: 15964094
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
9. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
10. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
11. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
[TBL] [Abstract][Full Text] [Related]
12. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
13. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response.
Leung PS; Suen PM; Ip SP; Yip CK; Chen G; Lai PB
Regul Pept; 2003 Nov; 116(1-3):61-9. PubMed ID: 14599716
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
Tazawa S; Nakane T; Chiba S
J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
Sun Y; Zhang JQ; Zhang J; Ramires FJ
J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
[TBL] [Abstract][Full Text] [Related]
18. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
19. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity.
Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW
Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465
[TBL] [Abstract][Full Text] [Related]
20. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
